FDA Has a Ticking Time Bomb with LDT Rule

PROPOSED REGULATION OF LABORATORY DEVELOPED TESTS (LDTs) by the federal Food and Drug Administration (FDA) may be the single topic of highest interest within the clinical laboratory and in vitro diagnostics (IVD) industries at this moment. If finalized in its draft form, the new regulation will radically transform a sector of laboratory medicine that uses […]